LJOClass II
Antigen, Iha, Cytomegalovirus
21 CFR 866.3175 / Microbiology
LJO is the FDA product code for Antigen, Iha, Cytomegalovirus, a class II device type, regulated under 21 CFR 866.3175. As of , FDA records hold 12 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- LJO
- Device name
- Antigen, Iha, Cytomegalovirus
- Regulation
- 21 CFR 866.3175
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 12
- Ingested recalls
- 0
Clearances, product code LJO
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1983 | 1 |
| 1984 | 1 |
| 1985 | 1 |
| 1991 | 1 |
| 1992 | 1 |
| 1996 | 2 |
| 1998 | 2 |
| 2000 | 1 |
| 2019 | 1 |
| 2021 | 1 |
Applicants with the most clearances
Product code LJO| Applicant | Clearances |
|---|---|
| Immucor, Inc. | 3 |
| Akers Research Corp. | 1 |
| BD Becton Dickinson Vacutainer Systems Preanalytic | 1 |
| Cetus Corp. | 1 |
| Diamedix Corp. | 1 |
| Qiagen | 1 |
| E.I. Dupont de Nemours & Co., Inc. | 1 |
| Hillcrest Biologicals | 1 |
| Instrumentation Laboratory Co. | 1 |
| Sienna Biotech, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
